Resources for You
Lamisil (terbinafine hydrochloride) Tablets and Oral Granules
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – November 2011 and April 2012
- Hearing Impairment and Vertigo.
- photosensitivity reactions
- ...terbinafine may convert extensive CYP2D6 metabolizers to poor metabolizer status.
PATIENT COUNSELING INFORMATION
- Photosensitivity reactions have been reported with the use of Lamisil. Patients should be advised to minimize exposure to natural and artificial sunlight (tanning beds or UVA/B treatment) while using Lamisil